PMV Pharmaceuticals, Inc. (PMVP)
1.13
-0.01
(-0.88%)
USD |
NASDAQ |
Jan 16, 16:00
1.13
0.00 (0.00%)
After-Hours: 20:00
PMV Pharmaceuticals EPS Diluted (Quarterly): -0.3974 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Puma Biotechnology, Inc. | 0.1736 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.06M |
| Total Expenses (Quarterly) | 21.06M |
| Enterprise Value | -68.19M |
| Earnings Yield | -140.2% |
| Normalized Earnings Yield | -140.15 |